Navigation Links
Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix™ Biliary Stents
Date:10/21/2010

fic EndoscopyBoston Scientific Endoscopy develops innovative technology for less invasive, more efficient gastrointestinal procedures.  

Cautionary Statement Regarding Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words.  These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance.  These forward-looking statements include, among other things, statements regarding new product launches and launch cadence, regulatory approvals, clinical trials, product performance, competitive offerings and market position.  If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.  These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.  As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.  

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors.  All of these factors are difficult or impossi
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Announces Results for Third Quarter Ended September 30, 2010
2. Boston Scientific Announces Global Launch of Journey™ Guidewire
3. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
4. Boston Scientific Welcomes Publication of Analysis Demonstrating Long-Term Survival Benefit for ICD Therapy
5. Boston Scientifics TAXUS® Element™ Stent Demonstrates Strong Outcomes in Diabetic Patients
6. Boston Scientific Announces Clinical Data Supporting Safety and Efficacy of Platinum Chromium PROMUS Element™ Stent
7. Boston Scientific to Acquire Asthmatx
8. Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds
9. Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
10. Boston Millennia Partners Portfolio Company CardioMEMS Signs Equity Investment and Exclusive Option to be Acquired for an Additional $375,000,000
11. Childrens Hospital Boston and Particle Sciences Cooperate on Translational Medicine Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 04, 2015 Research ... addition of Jain PharmaBiotech,s new report "Animal ... their offering. This report describes and ... medicine and pharmaceuticals as well as improvement in ... in the application of biotechnology to manage genetic ...
(Date:8/4/2015)... , Aug. 4, 2015 Among 1,000 U.S. ... yet only half of consumers surveyed are aware of ... ever used use them, according to findings from a ... community service partnership focused on improving the health and ... online survey polled 1,000 men and women, ages 21 ...
(Date:8/3/2015)... Aug. 4, 2015   The Intellectual Property ... world,s leading provider of intelligent information for businesses ... 2015 CMR Pharmaceutical R&D Factbook , the biopharmaceutical ... concerns around declines in R&D, the analysis identifies ... trillion milestone and forecasts sales to reach $1.3 ...
Breaking Medicine Technology:Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3New Study Finds Consumers are Leaving Money at the Pharmacy 2New Study Finds Consumers are Leaving Money at the Pharmacy 3Pharma Sales to Grow Beyond $1 Trillion 2
... Maine, Oct. 21, 2011 IDEXX Laboratories, Inc. (NASDAQ: ... quarter of 2011 increased 12% to $301.0 million, from $269.6 ... as defined below, was 8%. Earnings per diluted share ("EPS") ... $0.66, compared to $0.59 for the same period in the ...
... Corporation (OTCBB: CDXC), the creator of pTeroPure®, today announced ... William Spengler to its Board of Directors. Mr. Honig ... board. Barry Honig is a specialist ... Chairman of InterCLICK (ICLK), a $150 million NASDAQ company.  ...
Cached Medicine Technology:IDEXX Laboratories Announces Third Quarter Results 2IDEXX Laboratories Announces Third Quarter Results 3IDEXX Laboratories Announces Third Quarter Results 4IDEXX Laboratories Announces Third Quarter Results 5IDEXX Laboratories Announces Third Quarter Results 6IDEXX Laboratories Announces Third Quarter Results 7IDEXX Laboratories Announces Third Quarter Results 8IDEXX Laboratories Announces Third Quarter Results 9IDEXX Laboratories Announces Third Quarter Results 10IDEXX Laboratories Announces Third Quarter Results 11IDEXX Laboratories Announces Third Quarter Results 12IDEXX Laboratories Announces Third Quarter Results 13IDEXX Laboratories Announces Third Quarter Results 14ChromaDex Announces Appointment of Barry Honig, Michael Brauser and William Spengler to Its Board of Directors 2ChromaDex Announces Appointment of Barry Honig, Michael Brauser and William Spengler to Its Board of Directors 3
(Date:8/4/2015)... ... August 04, 2015 , ... ... examination now offered by the world renowned Beverly Hills facelift surgeon , ... through cosmetic surgery techniques helps individuals to achieve an outer appearance that meets ...
(Date:8/4/2015)... Denver, CO (PRWEB) , ... August 04, 2015 ... ... for skilled nursing homes and other long-term care facilities, today announced details of ... (QAPI) for nursing homes and centers. , Providigm’s QAPI Accreditation program , ...
(Date:8/4/2015)... (PRWEB) , ... August 04, ... ... its HealthCenter personal health record (PHR) product has achieved Office of the ... Inpatient EHR Certification from Drummond Group. HealthCenter delivers the highest quality personal ...
(Date:8/4/2015)... ... ... METTLER TOLEDO has announced an upcoming online symposium entitled ... and Merck. This free online seminar will be held on September 24, ... decisions with limited process understanding. Established methods have been developed to facilitate ...
(Date:8/4/2015)... ... ... The results of a three year clinical trial for the Argus II, a ... blindness, were published on June 23, 2015 in Ophthalmology , the journal of ... more commonly known as the “bionic eye,” is safe and effective for long-term treatment ...
Breaking Medicine News(10 mins):Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 3Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2Health News:“Bionic Eye” Implant for the Blind Proved Safe and Effective at the End of a Three Year Clinical Trial 2
... National Government Services subsidiary Medicare ... York and Connecticut, INDIANAPOLIS, May 5 WellPoint, ... Inc.,subsidiary was selected by the Centers for Medicare & ... Jurisdiction 13,which includes the states of New York and ...
... kidney disease from high blood pressure did not keep ... of African-Americans studied, according to long-term results of a ... in the Archives of Internal Medicine. , The largest ... the African American Study of Kidney Disease and ...
... more with exclusive summer ... travel packages for 2008., SAN RAFAEL, ... Hotels & Restaurants Group announced today a,series of travel packages for ... KN Tranquility Suite(TM) offers opulent, comfort-inspired,surroundings in the heart of Chicago,s ...
... 5 ConforMIS, Inc., a privately,held company that ... treatment of osteoarthritis and joint damage, today,announced the ... Officer.,The addition fully rounds out the executive team, ... Chief Executive Officer and Phil Licari,as Chief Operating ...
... fewer brain bleeds than aspirin, study finds , , MONDAY, May ... good as aspirin at preventing recurrent stroke and it causes ... Peking University First Hospital in Beijing shows. , The trial ... to 18 months and 359 patients who took aspirin for ...
... prescriptions for $10, more women,s health offerings, and $4 ... BENTONVILLE, Ark., May 5 While health care,costs ... Stores, Inc.,(NYSE: WMT ) is furthering its efforts ... costs and providing ongoing savings,through its pharmacy offerings., ...
Cached Medicine News:Health News:WellPoint Wins Medicare Administrative Contract Worth up to $323 Million 2Health News:Kidney disease worsens in a fourth of African-Americans despite therapy for hypertension 2Health News:KN Tranquility Suite(TM) Hosts Spa Indulgences and High-Tea Service on the Magnificent Mile 2Health News:KN Tranquility Suite(TM) Hosts Spa Indulgences and High-Tea Service on the Magnificent Mile 3Health News:ConforMIS Completes Executive Team With Addition of CFO 2Health News:Anti-Clotting Drug as Good as Aspirin at Stopping Second Stroke 2Health News:Wal-Mart Launches Phase Three of $4 Prescription Program 2Health News:Wal-Mart Launches Phase Three of $4 Prescription Program 3Health News:Wal-Mart Launches Phase Three of $4 Prescription Program 4
Inquire...
Inquire...
... new QIAvac 24 Plus vacuum manifold allows processing of ... tedious loading and unloading of spin columns into and ... Plus offers: Time savings ... DNA, PCR products, and RNA Convenience ...
... Vac Manifold is available to ... 30 minutes; the manifold is ... and a vacuum regulator with ... vacuum chamber, on/off switch, control ...
Medicine Products: